Mock D M, Malik M I
Department of Pediatrics, University of Iowa College of Medicine, Iowa City 52242.
Am J Clin Nutr. 1992 Aug;56(2):427-32. doi: 10.1093/ajcn/56.2.427.
Estimates of the plasma concentration of biotin differ considerably. Variation in detectability of biotin bound covalently to protein is one potential source of disagreement. In this study we determined the amount of biotin covalently bound to plasma protein. First, greater than 99% of free and reversibly bound biotin was removed by dialysis; then greater than 90% of covalently bound biotin was released by acid hydrolysis. For plasma samples from 11 normal adults, the ratio of covalently bound biotin to free biotin was 0.15 +/- 0.09 (mean +/- SD). Taking into account the additional biotin that is reversibly bound to protein, this study provides evidence that approximately 12% of total biotin in plasma is covalently bound, 7% is reversibly bound, and 81% is free. We conclude that covalently bound biotin cannot account for the reported sixfold increase in biotin detected after acid hydrolysis. We speculate that the reported increase was an artifact caused by substances produced during acid hydrolysis of plasma.
生物素血浆浓度的估计值差异很大。与蛋白质共价结合的生物素检测能力的差异是造成分歧的一个潜在原因。在本研究中,我们测定了与血浆蛋白共价结合的生物素量。首先,通过透析去除了超过99%的游离和可逆结合的生物素;然后通过酸水解释放了超过90%的共价结合生物素。对于11名正常成年人的血浆样本,共价结合生物素与游离生物素的比例为0.15±0.09(平均值±标准差)。考虑到与蛋白质可逆结合的额外生物素,本研究提供了证据表明血浆中约12%的总生物素是共价结合的,7%是可逆结合的,81%是游离的。我们得出结论,共价结合的生物素不能解释酸水解后检测到的生物素增加六倍的报道。我们推测,报道的增加是血浆酸水解过程中产生的物质导致的假象。